Global and regional governance of One Health and implications for global health security.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
25 02 2023
Historique:
received: 16 06 2021
revised: 15 07 2022
accepted: 11 08 2022
pubmed: 23 1 2023
medline: 3 3 2023
entrez: 22 1 2023
Statut: ppublish

Résumé

The apparent failure of global health security to prevent or prepare for the COVID-19 pandemic has highlighted the need for closer cooperation between human, animal (domestic and wildlife), and environmental health sectors. However, the many institutions, processes, regulatory frameworks, and legal instruments with direct and indirect roles in the global governance of One Health have led to a fragmented, global, multilateral health security architecture. We explore four challenges: first, the sectoral, professional, and institutional silos and tensions existing between human, animal, and environmental health; second, the challenge that the international legal system, state sovereignty, and existing legal instruments pose for the governance of One Health; third, the power dynamics and asymmetry in power between countries represented in multilateral institutions and their impact on priority setting; and finally, the current financing mechanisms that predominantly focus on response to crises, and the chronic underinvestment for epidemic and emergency prevention, mitigation, and preparedness activities. We illustrate the global and regional dimensions to these four challenges and how they relate to national needs and priorities through three case studies on compulsory licensing, the governance of water resources in the Lake Chad Basin, and the desert locust infestation in east Africa. Finally, we propose 12 recommendations for the global community to address these challenges. Despite its broad and holistic agenda, One Health continues to be dominated by human and domestic animal health experts. Substantial efforts should be made to address the social-ecological drivers of health emergencies including outbreaks of emerging, re-emerging, and endemic infectious diseases. These drivers include climate change, biodiversity loss, and land-use change, and therefore require effective and enforceable legislation, investment, capacity building, and integration of other sectors and professionals beyond health.

Identifiants

pubmed: 36682375
pii: S0140-6736(22)01597-5
doi: 10.1016/S0140-6736(22)01597-5
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

688-704

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests We declare no competing interests. The views and opinions expressed in this paper are those of the authors and not of their institutions.

Auteurs

Azza Elnaiem (A)

Royal Free London NHS Foundation Trust, London, UK.

Olaa Mohamed-Ahmed (O)

UK Health Security Agency, London, UK; Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: olaa.mohamed-ahmed@ukhsa.gov.uk.

Alimuddin Zumla (A)

Department of Infection, Division of Infection and Immunity, University College London, London, UK; National Institute for Health and Care Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.

Jeffrey Mecaskey (J)

DAI Global Health, London, UK.

Nora Charron (N)

DAI Global Health, London, UK.

Mahamat Fayiz Abakar (MF)

Institut de Recherche en Elevage pour le Développement, N'Djaména, Chad.

Tajudeen Raji (T)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Ammad Bahalim (A)

Harvard T H Chan School of Public Health, Boston, MA, USA.

Logan Manikam (L)

Global Health Programme, Royal Institute of International Affairs, London, UK.

Omar Risk (O)

Department of Population, Policy and Practice, University College London Great Ormond Street Institute of Child Health, London, UK.

Ebere Okereke (E)

Tony Blair Institute for Global Change, London, UK.

Neil Squires (N)

UK Health Security Agency, London, UK.

John Nkengasong (J)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Simon R Rüegg (SR)

Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

Muzamil M Abdel Hamid (MM)

Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.

Abdinasir Y Osman (AY)

Royal Veterinary College, University of London, London, UK.

Nathan Kapata (N)

Zambia National Public Health Institute, Ministry of Health, Lusaka, Zambia.

Robyn Alders (R)

Global Health Programme, Royal Institute of International Affairs, London, UK; Development Policy Centre, Australian National University, Canberra, ACT, Australia.

David L Heymann (DL)

Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Richard Kock (R)

Royal Veterinary College, University of London, London, UK.

Osman Dar (O)

Global Operations, London, UK; Global Health Programme, Royal Institute of International Affairs, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH